Aminocaproic Acid
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00513 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | severe nonproliferative diabetic retinopathy | KG + DL |
| 2 | diabetic retinopathy | KG + DL |
| 3 | renal osteodystrophy | KG + DL |
| 4 | atypical coarctation of aorta | KG + DL |
| 5 | primary release disorder of platelets | KG + DL |
| 6 | aortic malformation | KG + DL |
| 7 | impaired renal function disease | KG + DL |
| 8 | Glanzmann thrombasthenia | KG + DL |
| 9 | pseudo-von Willebrand disease | KG + DL |
| 10 | non-renal secondary hyperparathyroidism | KG + DL |
| 11 | bone remodeling disease | KG + DL |
| 12 | non-syndromic esophageal malformation | KG + DL |
| 13 | congenital prothrombin deficiency | KG + DL |
| 14 | hyperparathyroidism, transient neonatal | KG + DL |
| 15 | diabetic cataract | KG + DL |
| 16 | vitamin deficiency disorder | KG + DL |
| 17 | biotin metabolic disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.